Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: sylvester80 who wrote (1228877)	5/10/2020 1:21:22 PM
From: longnshort	2 Recommendations Recommended By locogringo TideGlider Read Replies (1) \| Respond to of 1576751

double boom Report: Efforts to Remove Dr. Rick Bright Predate Hydroxychloroquine; ‘Incompetence and Insubordination’ 3,451 Alliance for Health Policy / Flickr / CC / Cropped JOEL B. POLLAK23 Apr 20202955 3:01 Dr. Rick Bright, the vaccine expert who claims he was ousted from his former position in the administration because of his opposition to the promotion of hydroxychloroquine as a treatment for coronavirus, was already going to lose his job months before, according to information released on Twitter by Politico reporter Dan Diamond. Diamond commented in Twitter on January 2 — long before most Americans had heard of the coronavirus outbreak in China — that Dr. Bright, who was head of Biomedical Advanced Research and Development Authority (BARDA) until recently, had supervised Anand Shah, who was leaving the Centers for Medicare & Medicaid Services. Shah had worked for CMS Administrator Seema Verma. Dan Diamond ?@ddiamond · Jan 2, 2020 A top adviser to @SeemaCMS, ANAND SHAH, will leave CMS for new role advising commissioner @SteveFDA. t.co Scoop with @SarahKarlin Dan Diamond ?@ddiamond Shah, a practicing radiation oncologist, trained under Hahn at Penn and has helped with his transition. At CMS, Shah worked on the innovation portfolio, including an initiative to fight antimicrobial resistance with @BARDA director Rick Bright. 12 5:42 PM - Jan 2, 2020 Twitter Ads info and privacy See Dan Diamond's other Tweets In response, Diamond revealed a text message Wednesday, which he received Jan. 2, about Bright’s imminent removal from BARDA for “incompetence and insubordination.” That was months before hydroxychloroquine became a topic of debate. Dan Diamond ?@ddiamond · Apr 22, 2020 Replying to @ddiamond UPDATE: Rick Bright, vaccine expert who said he was ousted for opposing Trump’s drive to acquire malaria drugs, recently praised the acquisition in internal emails. t.co Dan Diamond ?@ddiamond The Trump administration has been working to oust Bright since last year, as officials battled with him over his management and leadership. With permission, sharing this time-stamped text from individual with knowledge of those fights. 717 7:05 PM - Apr 22, 2020 Twitter Ads info and privacy 505 people are talking about this Diamond later reported that in internal emails, Dr. Bright had praised the administration’s acquisition of the drug: Dan Diamond ?@ddiamond · Apr 22, 2020 Replying to @ddiamond POLITICO first wrote on March 27 about how Trump’s push for malaria drugs to fight Covid-19 was warping the health department’s response, and again on April 6 on health officials’ concerns (and being silenced). t.co Dan Diamond ?@ddiamond UPDATE: Rick Bright, vaccine expert who said he was ousted for opposing Trump’s drive to acquire malaria drugs, recently praised the acquisition in internal emails. t.co 914 6:59 PM - Apr 22, 2020 Twitter Ads info and privacy 777 people are talking about this Freelance journalist Jeryl Bier provided a letter from the Food and Drug Administration (FDA) referring to a request from Dr. Bright for an Emergency Use Authorization (EUA) for hydroxychloroquine and related compounds for treatment: jerylbier ?@JerylBier In March, Rick Bright requested the FDA issue an "Emergency Use Authorization (EUA) for emergency use of oral formulations of chloroquine phosphate and hydroxychloroquine sulfate for the treatment of 2019 coronavirus disease (COVID-19)..." t.co 561 9:34 PM - Apr 22, 2020 Twitter Ads info and privacy 446 people are talking about this Dr. Bright has portrayed himself as a victim of retaliation for his opposition to the widespread use of hydroxychloroquine. He was reassigned from BARDA to a job at the National Institutes of Health, and apparently has not yet reported to his post. He has retained the same attorneys who spearheaded Dr. Christine Blasey Ford’s accusations against Brett Kavanaugh in 2018. NBC News reported Thursday that Dr. Bright felt pressured to rush hydroxychloroquine into use after President Donald Trump spoke to Oracle Chairman Larry Ellison, a wealthy supporter of his who also sits on the economic re-opening council. Democrats plan to call Dr. Bright to testify before House committees, and want the Department of Health and Human Services inspector general to investigate Dr. Bright’s departure and his claims about the politicization of the agency. President Trump has suggested compassionate use of hydroxychloroquine, combined with azithromycin and zinc — a treatment for which there is anecdotal evidence, though there is not yet clinical conformation of its effectiveness. Joel B. Pollak is Senior Editor-at-Large at Breitbart News and the host of Breitbart News Sunday on Sirius XM Patriot on Sunday evenings from 7 p.m. to 10 p.m. ET (4 p.m. to 7 p.m. PT). His new book, RED NOVEMBER, is available for pre-order. He is a winner of the 2018 Robert Novak Journalism Alumni Fellowship. Follow him on Twitter at @joelpollak.